Is Intellia Therapeutics Inc (NASDAQ: NTLA) Proving The Doubters Wrong?
Intellia Therapeutics Inc (NTLA) concluded trading on Wednesday at a closing price of $13.12, with 4.45 million shares of worth about $58.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.48% during that period and on November 20, 2024 the price saw a […]
Do Intellia Therapeutics Inc (NASDAQ: NTLA) Fit In A Value Investing Philosophy?
Currently, there are 101.58M common shares owned by the public and among those 99.79M shares have been available to trade. The company’s stock has a 5-day price change of -28.89% and -42.81% over the past three months. NTLA shares are trading -50.84% year to date (YTD), with the 12-month market performance down to -35.28% lower. […]
Intellia Therapeutics Inc (NASDAQ: NTLA): To Buy Or Not To Buy, That Is The Question
Intellia Therapeutics Inc (NTLA) concluded trading on Thursday at a closing price of $15.85, with 11.36 million shares of worth about $180.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.83% during that period and on October 24, 2024 the price saw a […]
